Prognostic factors affecting survival in early-stage HER2-positive breast cancer treated with adjuvant therapy
AbstractPurpose: This study aimed to identify the prognostic and predictive factors affecting survival in patients with early-stage human epidermal growth factor receptor 2 (HER2) positive breast cancer who received adjuvant treatment.Materials and methods: A retrospective analysis was conducted on 124 female patients...